Effect of Teriflunomide on No Evidence of Disease Activity and Cognition in Patients With Relapsing–Remitting MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study
J Neurol 2023 Jul 05;[EPub Ahead of Print], MP Amato, R Bergamaschi, D Centonze, M Mirabella, GA Marfia, R Totaro, G Lus, V Brescia Morra, U Aguglia, C Comi, P Cavalla, M Zaffaroni, M Rovaris, LM Grimaldi, S Leoni, S Malucchi, E Baldi, M Romano, M Falcini, P Perini, M Assetta, E Portaccio, S Sommacal, N Olivieri, F Parodi, DS Todaro, N Grassivaro, A Farina, MM Mondino, M Filippi, M TrojanoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.